Current position:Home >Product >
2-Butenoic acid, 4,4,4-trifluoro-3-[(4-hydroxybutyl)amino]-, ethyl ester, (2Z)-
2-Butenoic acid, 4,4,4-trifluoro-3-[(4-hydroxybutyl)amino]-, ethyl ester, (2Z)-(564444-55-9)
- Name: 2-Butenoic acid, 4,4,4-trifluoro-3-[(4-hydroxybutyl)amino]-, ethyl ester, (2Z)-
- Synonyms:
- Molecular Formula:C10H16F3NO3
- Molecular Weight:
- CAS Registry Number:564444-55-9
- EINECS:
- Melting Point:
- Water Solubility:
Other Product
- 564442-06-4/1H-Benzimidazol-2-amine, N-(3,4-dimethoxyphenyl)-5,6-dimethoxy-1-[1,2,3,6-tetrahydro-1-(phenyl methyl)-4-pyridinyl]-
- 564442-07-5/1H-Benzimidazol-2-amine, 5,6-dimethoxy-1-[1,2,3,6-tetrahydro-1-(phenylmethyl)-4-pyridinyl]-N-(3,4 ,5-trimethoxyphenyl)-
- 564442-09-7/1H-Benzimidazol-2-amine, N-(4-fluorophenyl)-5,6-dimethoxy-1-[1,2,3,6-tetrahydro-1-(phenylmethyl) -4-pyridinyl]-
- 564444-18-4/2,4,6-Borazinetriamine, N,N',N''-tris[bis(methylamino)boryl]-N,N',N''-trimethyl-
- 564444-21-9/L-Lysine, L-prolyl-L-arginyl-L-lysyl-L-prolyl-L-lysyl-L-tryptophyl-L-a-aspartyl-
- 564444-23-1/L-Methionine, glycyl-L-arginyl-L-seryl-L-a-aspartylglycyl-L-leucyl-
- 564444-25-3/L-Aspartic acid, L-leucyl-L-prolyl-L-prolyl-L-a-aspartyl-L-valyl-L-glutaminyl-L-arginyl-L-valyl-
- 564444-31-1/3-Octenoic acid, 5,7-dihydroxy-, methyl ester, (3Z)-
- 564444-35-5/4(1H)-Quinazolinone, 2-(2,4,6-trimethyl-1-heptenyl)-
- 564444-43-5/1-Hexanol, 2-amino-4-methyl-, (2S)-
- 564444-44-6/2-Butenoic acid, 4,4,4-trifluoro-3-[(2-hydroxyethyl)amino]-, ethyl ester, (2Z)-
- 564444-45-7/2-Butenoic acid, 4,4,4-trifluoro-3-[(3-hydroxypropyl)amino]-, ethyl ester, (2Z)-
- 564444-46-8/2-Butenoic acid, 4,4,4-trifluoro-3-[[(1R)-1-(hydroxymethyl)-3-(methylthio)propyl]amino]-, ethyl ester, (2Z)-
- 564444-47-9/2-Butenoic acid, 4,4,4-trifluoro-3-[[(1R)-1-(hydroxymethyl)-2-phenylethyl]amino]-, ethyl ester, (2Z)-
- 564444-48-0/2-Butenoic acid, 4,4,4-trifluoro-3-[[(1R)-1-(hydroxymethyl)-3-methylbutyl]amino]-, ethyl ester, (2Z)-
- 564444-49-1/2-Butenoic acid, 4,4,4-trifluoro-3-[[(1S)-1-(hydroxymethyl)-2-(methylthio)ethyl]amino]-, ethyl ester, (2Z)-
- 564444-50-4/2-Pentenoic acid, 4,4,5,5,5-pentafluoro-3-[[(1R)-1-(hydroxymethyl)-3-methylbutyl]amino]-, ethyl ester, (2Z)-
- 564444-53-7/2-Butenoic acid, 4,4,4-trifluoro-3-[[(1R)-1-(hydroxymethyl)-3-methylpentyl]amino]-, ethyl ester, (2Z)-
- 564444-54-8/2-Butenoic acid, 4,4,4-trifluoro-3-[(6-hydroxyhexyl)amino]-, ethyl ester, (2Z)-
- 564444-55-9/2-Butenoic acid, 4,4,4-trifluoro-3-[(4-hydroxybutyl)amino]-, ethyl ester, (2Z)-
- 564444-57-1/2-Butenoic acid, 4,4,4-trifluoro-3-[[(1R)-1-(hydroxymethyl)-3-methylbutyl]methylamino]-, ethyl ester, (2E)-
- 564444-58-2/2-Butenoic acid, 4,4,4-trifluoro-3-[[(1R)-1-(hydroxymethyl)-2-methylpropyl]methylamino]-, ethyl ester, (2E)-
- 564444-59-3/1,4-Oxazepin-7(2H)-one, 3,4-dihydro-5-(trifluoromethyl)-
- 564444-60-6/2H-1,5-Oxazocin-2-one, 5,6,7,8-tetrahydro-4-(trifluoromethyl)-
- 564444-61-7/1,4-Oxazepin-7(2H)-one, 3,4-dihydro-3-[2-(methylthio)ethyl]-5-(trifluoromethyl)-, (3S)-
- 564444-62-8/1,4-Oxazepin-7(2H)-one, 3,4-dihydro-3-(phenylmethyl)-5-(trifluoromethyl)-, (3S)-
- 564444-63-9/1,4-Oxazepin-7(2H)-one, 3,4-dihydro-3-(2-methylpropyl)-5-(trifluoromethyl)-, (3S)-
- 564444-64-0/1,4-Oxazepin-7(2H)-one, 3,4-dihydro-3-[(methylthio)methyl]-5-(trifluoromethyl)-, (3R)-
- 564444-65-1/1,4-Oxazepin-7(2H)-one, 3,4-dihydro-3-(2-methylpropyl)-5-(pentafluoroethyl)-, (3S)-
- 564444-66-2/1,4-Oxazepin-7(2H)-one, 3,4-dihydro-3-[(methylthio)methyl]-5-(pentafluoroethyl)-, (3R)-